m****g
发帖数: 530 | 1 9 February 2010 - The National Institute for Health and Clinical Excellence
(NICE) said today it has updated
its draft guidance on the use of dasatinib (Sprycel, made by Bristol Myers-
Squibb (NYSE: BMY)) and nilotinib
(Tasigna, made by Novartis (VTX: NOVN)) for chronic myeloid leukaemia.
Following the previous public consultation and subsequent independent
Appraisal Committee meeting on
13 January 2010, both NICE and the appraisal committee agreed to split the
appraisal of dasatinib and
nilotin |
|
l*****t
发帖数: 190 | 2 母亲有病，需要nilotinib.急问。
从加拿大买药违法吗？
谢谢！ |
|
s******i
发帖数: 350 | 3 http://www.news-medical.net/news/20120618/Updated-data-from-ARI
"The pivotal PACE trial data show robust anti-leukaemic activity of
ponatinib in patients with CML at all stages, who are resistant or
intolerant to dasatinib or nilotinib, or who have the T315I mutation, a rare
form of CML which has no available treatment options," said Jane F.
Apperley, professor and chair, Department of Haematology at the Imperial
College, and the chief of service, Clinical Haematology, at the Imperial
College He... 阅读全帖 |
|
m****4
发帖数: 418 | 4 文章标题：Nilotinib interferes with the signaling pathways implicated in
acetaminophen hepatotoxicity。 有意速回站内信箱，请付简短自我介绍及相关背景
或相关发表的文章，以便向杂志推荐。 |
|
z***d
发帖数: 131 | 5 要出差， 没时间审。有意要推荐的，站内留名,简要经历及e-mail address。
Keyword: CML,nilotinib, targeted therapy.可能是篇review文章。
Journal 暂无 IF。 |
|
z***d
发帖数: 131 | 6 【 以下文字转载自 Immigration 讨论区 】
发信人: zymed (abcg), 信区: Immigration
标 题: Leukemia审稿机会
发信站: BBS 未名空间站 (Thu Jun 5 01:52:18 2014, 美东)
要出差， 没时间审。有意要推荐的，站内留名,简要经历及e-mail address。
Keyword: CML,nilotinib, targeted therapy.可能是篇review文章。
Journal 暂无 IF。 |
|
